Clinical Trials Logo

Schizophrenia; Psychosis clinical trials

View clinical trials related to Schizophrenia; Psychosis.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04277936 Terminated - Clinical trials for Schizophrenia; Psychosis

Pharmacologic Modulation of Hippocampal Activity in Psychosis

Start date: May 11, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test whether administration of levetiracetam (LEV), a commonly used anti-epileptic that alters neurotransmitter release, can reduce hippocampal hyperactivity. Specifically, we will utilize two functional magnetic resonance imaging (MRI) techniques: 1) blood oxygen level dependence (BOLD) contrast will assess activity with a visual scene processing task that engages the anterior hippocampus and 2) arterial spin labeling (ASL) will assess baseline activity. This study will also assess whether patients have improvement in their symptoms after receiving LEV. Previous studies in people with psychotic disorders have shown that the hippocampus is hyperactive and more activity correlates with worsening of clinical symptoms. Therefore, the aim of this study is to use an intervention to further understand the underlying mechanisms of the hippocampus in psychosis.